Celon Pharma Earnings inline, Revenue Beats In Q3
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Celon Pharma SA (CLNP)
Celon Pharma SA stock price live, this page displays WA CLNP stock exchange data. View the CLNP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Celon Pharma SA real time stock price chart below.
What Is the Celon Pharma SA Stock Price Today?
The Celon Pharma SA stock price today is 23.00.
What Is the Stock Symbol for Celon Pharma SA?
The stock symbol for Celon Pharma SA is ""CLNP.""
What Stock Exchange Does Celon Pharma SA Trade On?
Celon Pharma SA is listed and trades on the Warsaw stock exchange.
Is Celon Pharma SA a Good Stock to Buy?
Determining whether Celon Pharma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLNP quote. (ISIN: PLCLNPH00015)
What Is the Celon Pharma SA Stock Price Today?
The Celon Pharma SA stock price today is 23.00.
What Is the Stock Symbol for Celon Pharma SA?
The stock symbol for Celon Pharma SA is ""CLNP.""
What Stock Exchange Does Celon Pharma SA Trade On?
Celon Pharma SA is listed and trades on the Warsaw stock exchange.
Is Celon Pharma SA a Good Stock to Buy?
Determining whether Celon Pharma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLNP quote. (ISIN: PLCLNPH00015)
Warsaw
Currency in PLN
23.00
+0.25(+1.10%)
Closed·
Fair Value
An estimate of a Celon Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.65
23.10
52 wk Range
20.85
32.80
CLNP Scorecard
Full Analysis
Net income is expected to grow this year
CLNP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Celon Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.6523.10
52 wk Range
20.8532.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CLNP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Celon Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
27.44
Upside
+19.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Celon Pharma SA Company Profile
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.
Compare CLNP to Peers and Sector
Metrics to compare | CLNP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLNPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.2x | −3.7x | −0.6x | |
PEG Ratio | 0.59 | 0.58 | 0.00 | |
Price/Book | 3.0x | 3.5x | 2.6x | |
Price / LTM Sales | 5.8x | 3.5x | 3.3x | |
Upside (Analyst Target) | 23.1% | 31.6% | 39.0% | |
Fair Value Upside | Unlock | 12.8% | 4.9% | Unlock |
Analyst Ratings
2 Buy
2 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 27.44
(+19.30% Upside)
Earnings
Latest Release
May 21, 2025
EPS / Forecast
-0.47 / --
Revenue / Forecast
49.08M / 47.50M
People Also Watch
FAQ
What Stock Exchange Does Celon Pharma Trade On?
Celon Pharma is listed and trades on the Warsaw Stock Exchange stock exchange.
What Is the Stock Symbol for Celon Pharma?
The stock symbol for Celon Pharma is "CLNP."
What Is the Celon Pharma Market Cap?
As of today, Celon Pharma market cap is 1.24B.
What Is Celon Pharma's Earnings Per Share (TTM)?
The Celon Pharma EPS (TTM) is -0.83.
When Is the Next Celon Pharma Earnings Date?
Celon Pharma will release its next earnings report on 16 Sept 2025.
From a Technical Analysis Perspective, Is CLNP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Celon Pharma Stock Split?
Celon Pharma has split 0 times.
How Many Employees Does Celon Pharma Have?
Celon Pharma has 567 employees.
What is the current trading status of Celon Pharma (CLNP)?
As of 26 Aug 2025, Celon Pharma (CLNP) is trading at a price of 23.00, with a previous close of 22.75. The stock has fluctuated within a day range of 22.65 to 23.10, while its 52-week range spans from 20.85 to 32.80.
What Is Celon Pharma (CLNP) Price Target According to Analysts?
The average 12-month price target for Celon Pharma is PLN27.44, with a high estimate of PLN34 and a low estimate of PLN16. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +19.30% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.